Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab vs No-Induction in Low Immunological Risk Kidney Transplant Recipients
NCT04404127Phase 4Unknown
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Sep 2020
- Primary completion
- May 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of basiliximab in kidney transplant rejection, sponsored by King Faisal Specialist Hospital and Research Centre. Status: unknown.
02
Drugs
basiliximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT04404127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04404127.